Parth Sharma, IM Resident at UMKC Internal Medicine Residency Program, shared on X:
“Thrilled to present our research at ASCOGI25 highlighting the efficacy of HER-2 targeted therapies in biliary tract cancers!!! Grateful to my mentor Marc Roth for his guidance and all the co-authors for their support.“